Clinical Trial Update: Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity [Phase 2]

View source ↗

Summary

Phase 2 trial recruiting to evaluate whether SGLT2 inhibitors can reduce arterial stiffness in veterans with obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Vascular Disease

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: VA Office of Research and Development | Conditions: Obesity, Vascular Health | Phase 2 | Status: RECRUITING